Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meinhard Kieser

Showing results (1-10 of 234) with videos related to

Pageof 24
Sort By:
Pharmaceutical Statistics|June 22, 2016
Statistical methods for the analysis of adverse event dataMeinhard Kieser
Biometrical Journal. Biometrische Zeitschrift|July 23, 2013
Optimal adaptive two-stage designs for phase II cancer clinical trialsStefan Englert, Meinhard Kieser
Journal of Biopharmaceutical Statistics|April 27, 2019
Optimal adaptive single-arm phase II trials under quantified uncertaintyKevin Kunzmann, Meinhard Kieser
Statistics in Medicine|January 10, 2002
On the inappropriateness of an EM algorithm based procedure for blinded sample size re-estimationTim Friede, Meinhard Kieser
The British Journal of Mathematical and Statistical Psychology|October 7, 2011
A closer look at the effect of preliminary goodness-of-fit testing for normality for the one-sample t-testJustine Rochon, Meinhard Kieser
Biometrical Journal. Biometrische Zeitschrift|February 13, 2013
Sample size calculations for noninferiority trials with Poisson distributed count dataKathrin Stucke, Meinhard Kieser
Pharmaceutical Statistics|March 20, 2013
Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimationTim Friede, Meinhard Kieser
Statistics in Medicine|July 6, 2012
A general approach for sample size calculation for the three-arm 'gold standard' non-inferiority designKathrin Stucke, Meinhard Kieser
International Journal of Molecular Sciences|May 12, 2015
Optimal decision rules for biomarker-based subgroup selection for a targeted therapy in oncologyJohannes Krisam, Meinhard Kieser
Statistics in Medicine|March 11, 2003
Blinded sample size reassessment in non-inferiority and equivalence trialsTim Friede, Meinhard Kieser
Pageof 24

Showing results (1-10 of 234) with videos related to

Sort By:
Pageof 24
Pharmaceutical Statistics|June 22, 2016
Statistical methods for the analysis of adverse event dataMeinhard Kieser
Biometrical Journal. Biometrische Zeitschrift|July 23, 2013
Optimal adaptive two-stage designs for phase II cancer clinical trialsStefan Englert, Meinhard Kieser
Journal of Biopharmaceutical Statistics|April 27, 2019
Optimal adaptive single-arm phase II trials under quantified uncertaintyKevin Kunzmann, Meinhard Kieser
Statistics in Medicine|January 10, 2002
On the inappropriateness of an EM algorithm based procedure for blinded sample size re-estimationTim Friede, Meinhard Kieser
The British Journal of Mathematical and Statistical Psychology|October 7, 2011
A closer look at the effect of preliminary goodness-of-fit testing for normality for the one-sample t-testJustine Rochon, Meinhard Kieser
Biometrical Journal. Biometrische Zeitschrift|February 13, 2013
Sample size calculations for noninferiority trials with Poisson distributed count dataKathrin Stucke, Meinhard Kieser
Pharmaceutical Statistics|March 20, 2013
Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimationTim Friede, Meinhard Kieser
Statistics in Medicine|July 6, 2012
A general approach for sample size calculation for the three-arm 'gold standard' non-inferiority designKathrin Stucke, Meinhard Kieser
International Journal of Molecular Sciences|May 12, 2015
Optimal decision rules for biomarker-based subgroup selection for a targeted therapy in oncologyJohannes Krisam, Meinhard Kieser
Statistics in Medicine|March 11, 2003
Blinded sample size reassessment in non-inferiority and equivalence trialsTim Friede, Meinhard Kieser
Pageof 24